
SK Capital | Sustainably Transforming Companies
SK Capital is comprised of individuals that have spent their careers in the specialty materials, ingredients, and life sciences sectors as operators, owners, and investors. We leverage our differentiated experience to support management teams in transforming our companies.
About - SK Capital
SK Capital is a leading private investment firm focused on the specialty materials, ingredients, and life sciences sectors. These specialty sectors make up the building blocks of modern life and work to build a more sustainable future.
Portfolio - SK Capital
Mar 15, 2017 · SK Capital acquired SI Group in October 2018 and merged it with Addivant, a leading global producer of specialty additives and an SK Capital portfolio company since 2013. The combined Company is marketed under the SI Group brand.
Team - SK Capital
Team Archive | SK Capital. New York. 430 Park Avenue 18th Floor New York, NY 10022 T / 212 826-2700
SK Capital Partners Closes Catalyst Fund II at $800 Million
New York, NY, August 2, 2023 – SK Capital Partners, LP (“SK Capital” or the “Firm”), a private investment firm focused on the specialty materials, ingredients, and life sciences sectors, today announced the close of SKCP Catalyst Fund II (“Catalyst Fund II” or the “Fund”).
SK Capital Announces Agreement to Acquire North America …
New York, July 30, 2024 – SK Capital Partners (“SK Capital”), a New York-based private investment firm focused on the specialty materials, ingredients, and life sciences sectors, today announced it has signed a definitive agreement to acquire the North America Composites & Fuel Containment (“CFC”) Division of Parker Hannifin ...
Strategy - SK Capital
SK Capital applies the same investment principles across our entire portfolio and invests capital from two programs: Flagship and Catalyst. The Flagship strategy focuses on upper mid-sized and large companies, while Catalyst funds is dedicated to …
News - SK Capital
4 days ago · New York. 430 Park Avenue 18th Floor New York, NY 10022 T / 212 826-2700
SK Capital completes acquisition of Apotex, a global leader in ...
TORONTO – April 3, 2023 – Apotex Pharmaceutical Holdings Inc. (“Apotex” or the “Company”) today announced that its acquisition by an affiliate of funds advised by SK Capital Partners, LP (“SK Capital”) has closed.
SK Capital Closes Acquisition of North America Composites & Fuel ...
New York, November 4, 2024 – SK Capital, a private investment firm focused on the specialty materials, ingredients and life sciences sectors, completed its previously announced acquisition of the North America Composites & Fuel Containment Division of Parker Hannifin Corporation (NYSE: PH). The business, which has been renamed Axillon ...